A Randomized, Open-label, Cross-over Study in Two Periods and Two Sequences to Evaluate the Comparative Pharmacokinetics and Bioavailability of XC8, 10 mg Film-coated Tablets, and XC8, 40 mg Film-coated Tablets, When Taken Once in Equal Doses (40 mg) on an Empty Stomach in Healthy Volunteers
Latest Information Update: 12 Oct 2023
At a glance
- Drugs Histamine glutarimide (Primary)
- Indications Influenza virus infections; Respiratory tract infections
- Focus Pharmacokinetics
- Sponsors Valenta Pharmaceuticals
Most Recent Events
- 12 Oct 2023 Status changed from recruiting to completed.
- 04 Oct 2022 New trial record